1-3 of 3
Maya Leabman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Dose Escalation Study of Igm-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell Malignancies

Elizabeth Budde, Ajay K Gopal, Won Seog Kim, Ian W. Flinn, Chan Yoon Y. Cheah, Loretta Nastoupil, Matthew J. Matasar, Catherine S. Diefenbach, Gareth P Gregory, Ibrahim Qazi, Ching-Fai Pang, Maya Leabman, Genevive Hernandez, Iris Sison, Bruce A. Keyt, Daniel Chen, Philippe Armand
Journal: Blood
Blood (2021) 138 (Supplement 1): 132.
https://doi.org/10.1182/blood-2021-153355
Published: 2021
Journal Articles

Preliminary Results of a Phase 1 Dose Escalation Study of the First-in-Class IgM Based Bispecific Antibody Igm-2323 (anti-CD20 x anti-CD3) in Patients with Advanced B-Cell Malignancies

Elizabeth Budde, MDPhD, Ajay K. Gopal, MD, Ian W. Flinn, MD PhD, Loretta J. Nastoupil, MD, Michael S. Gordon, MD, Ching-Fai Pang, PhD, Bruce Keyt, PhD, Steve Carroll, PhD, Maya Leabman, PhD, Genevive Hernandez, PhD, Iris Sison, Daniel Chen, MD PhD, Wayne Godfrey, MD, Philippe Armand, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-134983
Published: 2020
Journal Articles

Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade

Wei Yu Lin, Qian Gong, Dhaya Seshasayee, Zhonghua Lin, Qinglin Ou, Shiming Ye, Eric Suto, Jean Shu, Wyne Pun Lee, Ching-Wei V. Lee, Germaine Fuh, Maya Leabman, Suhasini Iyer, Kathy Howell, Thomas Gelzleichter, Joseph Beyer, Dimitry Danilenko, Sherry Yeh, Laura E. DeForge, Allen Ebens, Jeffrey S. Thompson, Christine Ambrose, Mercedesz Balazs, Melissa A. Starovasnik, Flavius Martin
Journal: Blood
Blood (2007) 110 (12): 3959–3967.
https://doi.org/10.1182/blood-2007-04-088088
Published: 2007
Includes: Supplemental data